Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Extension Study in Bipolar Disorder
NCT00360126Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in bipolar disorder (BD), sponsored by GSK. Started Oct 2005; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00360126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360126.